| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/22/2008 | CA2705785A1 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669246A1 Use of gabapentin and pregabalin prodrugs for treating tinnitus |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2667587A1 Methods for treatment of cochlear and vestibular disorders |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1922073A1 New capped pyrazinoylguanidine sodium channel blockers |
| 05/21/2008 | EP1922062A2 Method of treatment or prevention of age-related macular degeneration |
| 05/21/2008 | EP1827417A4 Enhanced occlusive effect photodynamic therapy |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1078002B1 Peptide antiangiogenic drugs |
| 05/21/2008 | CN101182517A Multi-target point cocktail double strand small interfere RNA used for curing disease and method of producing same |
| 05/21/2008 | CN101181490A Chinese medicine composition orally taken for curing glaucoma |
| 05/21/2008 | CN101181489A Chinese medicine composition orally taken for curing glaucoma |
| 05/21/2008 | CN101181436A Chinese medicine composition orally taken for curing cataract |
| 05/21/2008 | CN101181433A Chinese medicine medicament for curing pterygium |
| 05/21/2008 | CN101181396A Externally used medicament for curing otopyosis |
| 05/21/2008 | CN101181279A Arificial tears containing trehalose as well as preparation and application method thereof |
| 05/21/2008 | CN101181253A Chloromycetin eyedrops with long shelf-life and preparation method thereof |
| 05/21/2008 | CN101181252A Chloromycetin eyedrops with long shelf-life and preparation method thereof |
| 05/21/2008 | CN101181251A Unimycetin eyedrops and preparation method thereof |
| 05/21/2008 | CN101181239A Unimycetin liquor for eye and preparation method thereof |
| 05/21/2008 | CN101181238A Unimycetin liquor for eye and preparation method thereof |
| 05/21/2008 | CN101181237A Chloromycetin eyedrops with long shelf-lifeand preparation method thereof |
| 05/21/2008 | CN101181228A Homatropine hydrobromide in-situ gel rubber preparations for dripping eyes and preparation method thereof |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100388923C Chinese-medicinal preparation and making method for treating acute corneitis and releasing visual fatigue |
| 05/21/2008 | CN100388919C Use of rimexolone in the treatment of dry eye |
| 05/21/2008 | CN100388915C Eye drop containing tranilast and its preparing process |
| 05/21/2008 | CA2580907A1 Choroid plexus cell implantation to prevent and/or treat hearing loss |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/15/2008 | WO2008057300A2 Trpvi antagonists and uses thereof |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008008660B1 Cyclopentane derivatives as antiglaucoma agents |
| 05/15/2008 | WO2007084765A3 Injectable combination therapy for eye disorders |
| 05/15/2008 | WO2007076351A3 Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis |
| 05/15/2008 | US20080114076 Biodegradable polyester; kits with syringes |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113935 dipalmitoyl or dimyristoyl phosphatidylethanolamine is conjugated with a monomer, dimer, oligomer or polymer selected from alginates, polygelin, carboxymethyl cellulose, hydroxyethylstarch, chondrotin sulfate etc directly or via a spacer; for treatment of retinopathy, glaucoma and other vision defects |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113900 Nutraceutical; reduce serum homocysteine levels; protects cells from damage and death when exposed to oxidative stress conditions; human food supplements, multivitamin preparations, breakfast foods, infant formulas, complete diet and weight-loss formulas and bars |
| 05/15/2008 | US20080113027 Water insoluble polymer matrix for drug delivery |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113002 Contact lens compositions |
| 05/15/2008 | US20080112983 Barn Dust Extract Providing Protection From Allergies |
| 05/15/2008 | CA2668556A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1920778A2 A composition, its preparation method and its use |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920764A1 Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension |
| 05/14/2008 | EP1919870A1 Ep2 receptor agonists for treating glaucoma |
| 05/14/2008 | EP1919862A2 Novel sulfonamides |
| 05/14/2008 | EP1919501A2 Method of treating glaucoma |
| 05/14/2008 | EP1919290A2 Methods and products for treatment of diseases |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | CN101180082A Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of SIV-PEDF vector |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387283C Chinese traditional medicine for treating diabetes retinopathy |
| 05/14/2008 | CN100387269C Schisandra chinensis soft capsule |
| 05/14/2008 | CN100387266C Medicinal composition for eyes, it's preparing process and use thereof |
| 05/14/2008 | CN100387260C Eye medicine for treating senile cataract and its pH value regulating method and preparing process thereof |
| 05/14/2008 | CN100387249C Traditional Chinese medicine formulation for treating ulcer |
| 05/14/2008 | CN100387220C Preparation for eyes and preparing method thereof |
| 05/14/2008 | CN100387154C Health-care food for relieving-vision fatigue and its preparation method |
| 05/13/2008 | US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/13/2008 | CA2252758C Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
| 05/08/2008 | WO2008054639A2 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008053982A1 Composition for treating allergy |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053602A1 5-(1h-1,2,3-triazol-4-yl)-1h-pyrazole derivative |
| 05/08/2008 | WO2008008718B1 Cyclopentane derivatives as antiglaucoma agents |